SWG Educational Activities
EHA-SWG meetings held in the past calendar year
- Joint MPN/MDS/AML meeting scheduled for 2021 has to be postponed due to the COVID-19 Pandemic. This 2-and-a-half-day meeting is now scheduled for November 2-4, 2024 in Budapest: EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms (https://ehaweb.org/meetings/swg-mds-mpn-aml/)Spetses Summer School INTERCEPT-MDS, August 28 to September 3, 2022, Greece. This basic research meeting offers an intensive mentoring program for up to 100 junior researchers and was co-organized by members of the SWG MDS and SWG AML (https://intercept-mds.eu/spetses)
Presentations at national and international meetings on behalf of the EHA-SWG
- ELN Symposium with 20. KNL Symposium September 2021, Session 2: WP5 AML Clinical trials involving the SWG: Discussion on potential areas of collaboration between EHA and ELN AML working groups (Konstanze Döhner, Gert Ossenkoppele)
- Opening lecture at the meeting of the Italian society of experimental hematology in Rome, March 31 to April 2, 2022: Molecular pathogenesis and prognostic stratification of AML (Konstanze Döhner)
Collaborations on international projects promoted by/involving the SWG
- Joint HOVON-AMLSG clinical trials including a large number of international cooperators/study groups (https://hovon.nl/en/about-hovon; https://www.cto-im3.de/amlsg/)
Translational work promoted by or involving the SWG
- HARMONY projects: i) measurable residual disease as surrogate marker for survival in AML; ii) optimizing APL management using big data, iii) big data to evaluate the clinical impact of genomic alterations
- Collaboration between HOVON and UK AML NCRI Group on novel AI-based prognostic scoring system for newly diagnosed AML patients > 60 years old treated with intensive chemotherapy and allo-SCT in prospective randomised trials.
Grants received by SWG-related networks or principal investigators
- EHA Support to SWG-initiated small research projects “evaluating the prognostic impact of subclonal FLT3-ITD mutations in acute myeloid leukemia, a retrospective multicenter study on behalf of the EHA AML-SWG, approved 02/2023
Other social & public EHA-related activities
- EHA-Campus: Master class on AML 2021/2022 (Konstanze Döhner)
- Annual EHA congress 2022, Vienna, Austria:
- EHA session on education: “Learning to Learn: Adult education and principles and myths”, Friday June 10, 2023 (Konstanze Döhner & Antonio Almeida)
- Education session: Towards precision medicine in AML; two presentations were given: 1) Validated prognostic and therapeutic targets (Hartmut Döhner), 2) Targeted therapies: Current status and perspectives, including maintenance (Jordi Esteve)
- Education Session: AML in the elderly unfit patient; two presentations were given: 1) Molecular landscape in elderly AML (Lars Bullinger), 2) Defining the fitness of elderly patients (Maria Teresa Voso)
- DGHO Jahrestagung, October 2022, Vienna, Austria: EHA talk on the Core Curriculum in Hematology, Friday October 7, 13:30-15:00, 2023 (Konstanze Döhner)